These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32374062)

  • 21. Cushing's syndrome from topical glucocorticoids.
    Teelucksingh S; Bahall M; Coomansingh D; Suite M; Bartholomew C
    West Indian Med J; 1993 Jun; 42(2):77-8. PubMed ID: 8367969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cushing's syndrome induced by high-potency topical corticosteroids.
    Demirsoy EO; Bilen N; Aktürk AS; Kocaoğlu Ö; Mutlu GY
    Int J Dermatol; 2014 Jan; 53(1):e20-2. PubMed ID: 22591336
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute and persistent iatrogenic Cushing's syndrome after a single dose of triamcinolone acetonide.
    Iglesias P; González J; Díez JJ
    J Endocrinol Invest; 2005 Dec; 28(11):1019-23. PubMed ID: 16483182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged childhood Cushing's syndrome secondary to intralesional triamcinolone acetonide.
    Teelucksingh S; Balkaran B; Ganeshmoorthi A; Arthur P
    Ann Trop Paediatr; 2002 Mar; 22(1):89-91. PubMed ID: 11926057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iatrogenic Cushing's Syndrome Due to Topical Ocular Glucocorticoid Treatment.
    Fukuhara D; Takiura T; Keino H; Okada AA; Yan K
    Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28104732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iatrogenic Cushing's syndrome in children presenting at Children's Hospital Lahore using nappy rash ointments.
    Sattar H; Manzoor J; Mirza L; Sheikh AM; Butt TA
    J Pak Med Assoc; 2015 May; 65(5):463-6. PubMed ID: 26028377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature.
    Tempark T; Phatarakijnirund V; Chatproedprai S; Watcharasindhu S; Supornsilchai V; Wananukul S
    Endocrine; 2010 Dec; 38(3):328-34. PubMed ID: 20972726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical-steroid-induced iatrogenic Cushing syndrome in the pediatric age group: A rare case report.
    Tiwari A; Goel M; Pal P; Gohiya P
    Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S257-8. PubMed ID: 24251179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of cardiovascular events in people prescribed glucocorticoids with iatrogenic Cushing's syndrome: cohort study.
    Fardet L; Petersen I; Nazareth I
    BMJ; 2012 Jul; 345():e4928. PubMed ID: 22846415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythrodermic psoriasis associated with hyperuricemia and Iatrogenic Cushing's syndrome due to topical corticosteroid therapy.
    Ohnishi T; Suzuki T; Watanabe S; Takahashi H
    Int J Dermatol; 1996 May; 35(5):379-80. PubMed ID: 8734668
    [No Abstract]   [Full Text] [Related]  

  • 31. Inappropriate use of potent topical glucocorticoids in infants.
    Ozon A; Cetinkaya S; Alikasifoglu A; Gonc EN; Sen Y; Kandemir N
    J Pediatr Endocrinol Metab; 2007 Feb; 20(2):219-25. PubMed ID: 17396439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cushing Syndrome Induced by Topical Corticosteroids for the Treatment of Lichen Sclerosus.
    Notay M; Fazel N; Awasthi S
    J Pediatr Adolesc Gynecol; 2019 Feb; 32(1):83-85. PubMed ID: 30244192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iatrogenic Cushing's syndrome following short-term intranasal steroid use.
    Dutta D; Shivaprasad KS; Ghosh S; Mukhopadhyay S; Chowdhury S
    J Clin Res Pediatr Endocrinol; 2012 Sep; 4(3):157-9. PubMed ID: 22985615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fatal outcome of Netherton syndrome due to excessive use of topical corticosteroids in an adult patient].
    Valette C; Ofaiche J; Severino M; Mazereeuw-Hautier J
    Ann Dermatol Venereol; 2020 Jan; 147(1):36-40. PubMed ID: 31653452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iatrogenic hyperadrenocorticism during topical steroid therapy: assessment of systemic effects by metabolic criteria.
    Cook LJ; Freinkel RK; Zugerman C; Levin DL; Radtke R
    J Am Acad Dermatol; 1982 Jun; 6(6):1054-60. PubMed ID: 7047591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different Potent Glucocorticoids, Different Routes of Exposure but the Same Result: Iatrogenic Cushing’s Syndrome and Adrenal Insufficiency.
    Güven A
    J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):383-392. PubMed ID: 32431136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cushing syndrome following external glucocorticoid administration in psoriasis].
    Dhein S
    Z Hautkr; 1986 Feb; 61(3):161-6. PubMed ID: 3953135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenal insufficiency as a result of long-term misuse of topical corticosteroids.
    Böckle BC; Jara D; Nindl W; Aberer W; Sepp NT
    Dermatology; 2014; 228(4):289-93. PubMed ID: 24751677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iatrogenic Cushing's syndrome due to dexamethasone nasal drops.
    Kimmerle R; Rolla AR
    Am J Med; 1985 Oct; 79(4):535-7. PubMed ID: 4050838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of iatrogenic Cushing syndrome: questions of glucocorticoid withdrawal].
    Igaz P; Rácz K; Tóth M; Gláz E; Tulassay Z
    Orv Hetil; 2007 Feb; 148(5):195-202. PubMed ID: 17344139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.